Sunyoung S Lee
Overview
Explore the profile of Sunyoung S Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yim S, Lee S, Baek S, Sohn B, Jeong Y, Kang S, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 40012401
No abstract available.
2.
Hu Z, Pavlick D, Ross J, Lee S, Eluri M, Javle M
JCO Precis Oncol
. 2025 Jan;
9:e2400712.
PMID: 39772832
Purpose: Biliary tract cancers (BTCs) include intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder cancers. BTCs have a number of genomic alterations, including isocitrate dehydrogenase 1 () mutations, fibroblast growth...
3.
Chamseddine S, Yavuz B, Mohamed Y, Lee S, Yao J, Hu Z, et al.
J Immunother Precis Oncol
. 2024 Nov;
7(4):255-262.
PMID: 39524465
Introduction: Galectin-3 plays critical roles in the adhesion, proliferation, and differentiation of tumor cells. Recent data have suggested that galectin-3 plays a role in the development of hepatocellular carcinoma (HCC);...
4.
DiPeri T, Evans K, Scott S, Zheng X, Varadarajan K, Kwong L, et al.
Clin Cancer Res
. 2024 Nov;
31(2):387-402.
PMID: 39513959
Purpose: Biliary tract cancers, which are rare and aggressive malignancies, are rich in clinically actionable molecular alterations. A major challenge in the field is the paucity of clinically relevant biliary...
5.
LaPelusa M, Chamseddine S, Tran Cao H, Xiao L, Hasanov E, Bhosale P, et al.
Oncology
. 2024 Oct;
:1-8.
PMID: 39427654
Introduction: Perioperative immunotherapy has shown promise in some patients with early-stage hepatocellular carcinoma (HCC). This study examined tissue and imaging biomarkers associated with pathologic response in a phase II clinical...
6.
Lee S, Yim S, Kim J, Lee S, Kaseb A, Lee J
Clin Mol Hepatol
. 2024 Oct;
31(1):e81-e83.
PMID: 39370716
No abstract available.
7.
Yim S, Lee S, Kim J, Lee S, Kaseb A, Lee J
Clin Mol Hepatol
. 2024 Oct;
31(1):e84-e86.
PMID: 39370715
No abstract available.
8.
Lee S, Yim S, Kim J, Lee S, Kaseb A, Wei P, et al.
Clin Mol Hepatol
. 2024 Oct;
31(1):e110-e112.
PMID: 39355874
No abstract available.
9.
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer A, et al.
medRxiv
. 2024 Sep;
PMID: 39314943
Background: Although escalated doses of radiation therapy (RT) for intrahepatic cholangiocarcinoma (iCCA) are associated with durable local control (LC) and prolonged survival, uncertainties persist regarding personalized RT based on biological...
10.
Mohamed Y, Lee S, Demir T, Chamseddine S, Hu Z, Xiao L, et al.
Cancer Biomark
. 2024 Sep;
41(1):83-91.
PMID: 39269823
Background: Circulating tumor DNA (ctDNA) is a promising non-invasive marker for detection, diagnosis, treatment selection, and prognosis of hepatocellular carcinoma (HCC). Objective: This study aimed to examine the utility of...